Journal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 63, Issue 3, Pages 201-214Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.10.041
Keywords
biomarkers; coronary stent(s); myocardial infarction; plaque rupture; platelets; thrombosis; troponin
Categories
Funding
- Amgen
- Daiichi-Sankyo
- Merck
- AstraZeneca
- Johnson Johnson
- Beckman Coulter
- Roche Diagnostics
- Sanofi-Aventis
- GlaxoSmithKline
- Bristol-Myers Squibb